PLRX
Price
$11.21
Change
-$0.39 (-3.36%)
Updated
Jan 17 closing price
Capitalization
682.17M
45 days until earnings call
TRDA
Price
$12.69
Change
+$0.15 (+1.20%)
Updated
Jan 17 closing price
Capitalization
474.86M
53 days until earnings call
Ad is loading...

PLRX vs TRDA

Header iconPLRX vs TRDA Comparison
Open Charts PLRX vs TRDABanner chart's image
Pliant Therapeutics
Price$11.21
Change-$0.39 (-3.36%)
Volume$672.62K
Capitalization682.17M
Entrada Therapeutics
Price$12.69
Change+$0.15 (+1.20%)
Volume$106.64K
Capitalization474.86M
PLRX vs TRDA Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. TRDA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (PLRX: $11.21 vs. TRDA: $12.69)
Brand notoriety: PLRX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 121% vs. TRDA: 87%
Market capitalization -- PLRX: $682.17M vs. TRDA: $474.86M
PLRX [@Biotechnology] is valued at $682.17M. TRDA’s [@Biotechnology] market capitalization is $474.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 2 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • PLRX’s TA Score: 2 bullish, 4 bearish.
  • TRDA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а -6.66% price change this week, while TRDA (@Biotechnology) price change was -13.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

PLRX is expected to report earnings on May 12, 2025.

TRDA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($682M) has a higher market cap than TRDA($475M). PLRX YTD gains are higher at: -14.882 vs. TRDA (-26.605). TRDA has higher annual earnings (EBITDA): 61.3M vs. PLRX (-197.04M). TRDA has more cash in the bank: 449M vs. PLRX (405M). PLRX (60.2M) and TRDA (61.3M) have identical debt. TRDA has higher revenues than PLRX: TRDA (215M) vs PLRX (0).
PLRXTRDAPLRX / TRDA
Capitalization682M475M144%
EBITDA-197.04M61.3M-321%
Gain YTD-14.882-26.60556%
P/E RatioN/A8.81-
Revenue0215M-
Total Cash405M449M90%
Total Debt60.2M61.3M98%
TECHNICAL ANALYSIS
Technical Analysis
PLRXTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGDMX112.351.05
+0.94%
Fidelity Advisor Communication ServicesA
ISGNX15.670.12
+0.77%
Columbia Integrated Small Cap Gr Instl
NIEAX14.880.11
+0.74%
BNY Mellon International Equity A
TEMTX25.620.12
+0.47%
Franklin Mutual Shares C
INFFX9.940.01
+0.10%
Tortoise Energy Infrastructure and Inc C

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with RCKT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-3.36%
RCKT - PLRX
51%
Loosely correlated
+0.98%
NTLA - PLRX
51%
Loosely correlated
+0.85%
PRME - PLRX
50%
Loosely correlated
+0.70%
CRSP - PLRX
50%
Loosely correlated
+0.57%
BEAM - PLRX
49%
Loosely correlated
+0.17%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with PLRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.20%
PLRX - TRDA
52%
Loosely correlated
-3.36%
RXRX - TRDA
48%
Loosely correlated
+2.03%
CRNX - TRDA
47%
Loosely correlated
+2.38%
MGTX - TRDA
47%
Loosely correlated
+5.56%
STRO - TRDA
46%
Loosely correlated
+8.65%
More